Dr Andrew Stephens
Cancer Biology Advisor
Dr Stephens is a leading cancer biology researcher with over 20 years’ experience in ovarian cancer and novel treatment research
Following his PhD, Andrew held postdoctoral positions at the University of Sydney and Prince Henry’s Institute. In 2009, he established the Ovarian Cancer Biomarkers group at Hudson Institute of medical Research in Melbourne to specifically drive new research into the design and development of diagnostic tools, and to improve the detection and management of ovarian cancers. Along with his team, he has published extensively and holds several patents detailing new diagnostic and therapeutic technologies for ovarian cancer management.
Andrew has a PhD in Biochemistry from Monash University and a Fellowship at the Ovarian Cancer Research Foundation (OCRF).
Prof. Sebastian Marcuccio
Dr Marcuccio is an organic / pharmaceutical chemist with over 30 years’ experience in research and commercial development.
Seb has extensive career experience in the development of fine chemical products and in drug discovery. He was previously Project Leader of Pharmaceutical Chemicals Research at CSIRO (Australia’s premier public research organisation) where he developed CSIRO’s complex organoboron technology, leading to multiple international patents and the establishment of Boron Molecular Pty Ltd, where he was the founding scientist and R&D Director 2001-2004.
Seb is currently Founder and Director at Advanced Molecular Technologies Pty Ltd (AMT), a contract research organisation specialising in medicinal chemistry and custom organic synthesis.
Seb has a PhD in Organic chemistry from ANU and is an adjunct professor at La Trobe University.
Alex is an Applied Physicist-Mathematician BSc(Hons) with over 35 years experience in the research and development, manufacturing and commercialisation of scientific instrumentation.
Alex has worked on research, analytical, forensic and medical devices, including ISO:9001 and ISO:13485 certifications for forensic and medical light source manufacturing. Alex was General Manager of Forensic Light Sources for Rofin Australia Pty Ltd which won the Australian Small to Medium Business Export Award in 2005. Alex also managed a 3 year Medical Light Source trial for PDT treatment of skin cancers at the Peter McCallum Cancer Centre, resulting in medical device certification for Australia and Europe in 2011. He has presented many international papers and seminars on light sources around the world.
Alex has been a Technical Adviser to Invion on PDT light sources since September 2018.
Manufacturing and Quality Adviser
Louise has over 35 years of experience in the pharmaceutical industry and has held key roles in leading global organisations.
Her experience includes 13 years in Australia’s leading a sterile vaccine manufacturing company, CSL andover 22 years within SeerPharma. Louise also held senior roles in Virology R&D, Bacterial Vaccines Production, Quality Control and Production Planning.
Further, she is a registered auditor for the Australian Pesticides and Veterinary
Manufacturing Authority (APVMA) and is a current Partner at SeerPharma.